QOL Medical LLC
Chase Nichols is a Senior Rare Disease Specialist at QOL Medical LLC, with a strong track record in the pharmaceutical industry, including recognition in the 2024 President’s Club for both growth and volume in the fields of gastroenterology and rare diseases. Previously, Chase served as a Territory Manager at Salix Pharmaceuticals, where achievements included the 2021 President’s Club - Rookie Of The Year, focusing on gastroenterology, hepatology, and primary care markets. Early career experience includes a role as a Primary Care Sales Representative at Astellas Pharma US, emphasizing urology and internal medicine. In addition to pharmaceutical expertise, Chase has a background in coaching football, having worked with the University of South Alabama. Chase holds a Bachelor’s degree in Business Administration and Management from St John’s River State College and an Associate's degree from the University of South Alabama.
This person is not in any offices
QOL Medical LLC
OL Medical is a specialty biopharmaceutical company dedicated to improving the quality of life for patients with rare diseases, for their families, and for the physicians and caregivers who support them.QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan products in underservedmarkets. QOL Medical ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases. The Company currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection, 5%.QOL Medical, in its commitment to assuring safe and effective products for our customers, uses validated procedures through audited and approved vendors for manufacturing, testing, and distribution. Additionally, QOL Medical has procedures for product monitoring, customer complaints, investigations into nonconformities, and change control.